E2F1: A potential negative regulator of hTERT transcription in normal cells upon activation of oncogenic c-Myc

Medical Science Monitor

Volumn 18, Issue 1, 2012, Pages

  Zhang, Yafei ^a   Chen, Ling ^a   Yang, Shiming ^a   Fang, Dianchun ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

c Myc; E2F1; Feedback regulation; hTERT; miR 17 92 cluster

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR E2F1;

CARCINOGENESIS; CELL DEATH; CELL FATE; CELL GROWTH; CELL IMMORTALIZATION; CELL TRANSFORMATION; ENZYME ACTIVATION; GENE ACTIVATION; GENE INDUCTION; GENETIC REGULATION; GENETIC TRANSCRIPTION; HUMAN; NEGATIVE FEEDBACK; ONCOGENE C MYC; PROTEIN EXPRESSION; PROTEIN INDUCTION; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH;

EID: 84855261286     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.882192     Document Type: Review

References (30)

1. Dang CV, O'Donnell KA, Zeller KI et al: The c-Myc target gene network. Semin Cancer Biol, 2006; 16: 253-64
2. Albihn A, Johnsen JI, Henriksson MA: MYC in oncogenesis and as a target for cancer therapies. Adv Cancer Res, 2010; 107: 163-224
3. Pelengaris S, Khan M: The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth. Expert Opin Ther Targets, 2003; 7: 623-42
4. Strasser A, Harris AW, Bath ML, Cory S: Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature, 1990; 348: 331-33
5. Verdun RE, Karlseder J: Replication and protection of telomeres. Nature, 2007; 447: 924-31
6. Hu J, Yuan R: The expression levels of stem cell markers importin13, ckit, CD146, and telomerase are decreased in endometrial polyps. Med Sci Monit, 2011; 17(8): BR221-27
7. Kilian A, Bowtell DD, Abud HE et al: Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet, 1997; 6: 2011-19
8. Counter CM, Meyerson M, Eaton EN et al: Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene, 1998; 16: 1217-22
9. Kim NW, Piatyszek MA, Prowse KR et al: Specific association of human telomerase activity with immortal cells and cancer. Science, 1994; 266: 2011-15
10. Land H, Parada LF, Weinberg RA: Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature, 1983; 304: 596-602
11. Wu KJ, Grandori C, Amacker M et al: Direct activation of TERT transcription by c-MYC. Nat Genet, 1999; 21: 220-24
12. Bell LA, Ryan KM: Life and death decisions by E2F-1. Cell Death Differ, 2004; 11: 137-42
13. Wu Z, Zheng S, Yu Q: The E2F family and the role of E2F1 in apoptosis. Int J Biochem Cell Biol, 2009; 41: 2389-97
14. Crowe DL, Nguyen DC, Tsang KJ, Kyo S: E2F-1 represses transcription of the human telomerase reverse transcriptase gene. Nucleic Acids Res, 2001; 29: 2789-94
15. Lacerte A, Korah J, Roy M et al: Transforming growth factor-beta inhibits telomerase through SMAD3 and E2F transcription factors. Cell Signal, 2008; 20: 50-59
16. Elliott KA, Rickords LF, Labrum JM: Transduction of E2F-1 TAT fusion proteins represses expression of hTERT in primary ductal breast carcinoma cell lines. Mol Cancer, 2008; 7: 28
17. Matsumura I, Tanaka H, Kanakura Y: E2F1 and c-Myc in cell growth and death. Cell Cycle, 2003; 2: 333-38
18. Leone G, DeGregori J, Sears R et al: Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature, 1997; 387: 422-26
19. Fernandez PC, Frank SR, Wang L et al: Genomic targets of the human c-Myc protein. Genes Dev, 2003; 17: 1115-29
20. Coller HA, Forman JJ, Legesse-Miller A: "Myc'ed messages": myc induces transcription of E2F1 while inhibiting its translation via a microRNA polycistron. PLoS Genet, 2007; 3: e146
21. O'Donnell KA, Wentzel EA, Zeller KI et al: c-Myc-regulated microRNAs modulate E2F1 expression. Nature, 2005; 435: 839-43
22. Sylvestre Y, De Guire V, Querido E et al: An E2F/miR-20a autoregulatory feedback loop. J Biol Chem, 2007; 282: 2135-43
23. Aguda BD, Kim Y, Piper-Hunter MG et al: MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proc Natl Acad Sci USA, 2008; 105: 19678-83
24. Rounbehler RJ, Rogers PM, Conti CJ, Johnson DG: Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model. Cancer Res, 2002; 62: 3276-81
25. Baudino TA, Maclean KH, Brennan J et al: Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss. Mol Cell, 2003; 11: 905-14
26. Conner EA, Lemmer ER, Sánchez A et al: E2F1 blocks and c-Myc accelerates hepatic ploidy in transgenic mouse models. Biochem Biophys Res Commun, 2003; 302: 114-20
27. Zeller KI, Jegga AG, Aronow BJ et al: An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets. Genome Biol, 2003; 4: R69
28. Kyo S, Takakura M, Fujiwara T, Inoue M: Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers. Cancer Sci, 2008; 99: 1528-38
29. Polager S, Ginsberg D: E2F at the crossroads of life and death. Trends Cell Biol, 2008; 18: 528-35
30. Alonso MM, Fueyo J, Yung WK, Gomez-Manzano C: E2F1 and telomerase: alliance in the dark side. Cell Cycle, 2006; 5: 930-35